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inflammatory mediators. 23
• Inhibition of afferent mechanosensitivity by galanin is not observed in tissues isolated 24 from mice undergoing DSS-induced colitis 25
• Galanin inhibits the transmission of noxious mechanical stimuli by colonic afferents 26 and its sensitisation by inflammatory mediators highlighting an antinociceptive role for 27 galanin in the colon. Galanin is a neuropeptide expressed by sensory neurones innervating the gastrointestinal (GI) 30 tract. Galanin displays inhibitory effects on vagal afferent signalling within the upper GI tract, 31 and the goal of this study was to determine the actions of galanin on colonic spinal afferent 32 function. Specifically, we sought to evaluate the effect of galanin on lumbar splanchnic nerve 33 (LSN) mechanosensitivity to noxious distending pressures and the development of 34 hypersensitivity in the presence of inflammatory stimuli and colitis. Using ex vivo 35 electrophysiological recordings we show that galanin produces a dose-dependent inhibition of 36 colonic LSN responses to mechanical stimuli and prevents the development of hypersensitivity 37 to acutely administered inflammatory mediators. Using galanin receptor (GalR) agonists, we 38
show that GalR1 activation, but not GalR2/3 activation, inhibits mechanosensitivity. The 39 inhibitory effect of galanin on colonic afferent activity was not observed in tissue from mice 40 with dextran sodium sulphate-induced colitis. We conclude that galanin has a marked 41 inhibitory effect on colonic mechanosensitivity at noxious distending pressures and prevents 42 the acute development of mechanical hypersensitivity to inflammatory mediator, an effect not 43 seen in the inflamed colon. These actions highlight a potential role for galanin in the regulation 44 of mechanical nociception from the bowel and the therapeutic potential of targeting 45 galaninergic signalling to treat visceral hypersensitivity. 46
Introduction 47
Visceral hypersensitivity is commonly observed in patients with gastrointestinal (GI) diseases, 48 such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), and contributes 49 to the presence of pain in these conditions (Chang et al., 2000; Ritchie, 1973) . In the periphery, 50 distal terminals of sensory neurones transduce noxious stimuli to produce nociception and the 51 sensation of pain (Grundy et al., 2019; Hockley et al., 2018; St John Smith, 2018) . The 52 persistent activation of these sensory nerve endings in response to disease driven changes 53 in the bowel microenvironment (e.g. the production of inflammatory mediators such as 54 prostaglandins), coupled with longer term changes in the plasticity of the sensory nerve 55 endings and subsequent sensitisation of central pain pathways, contribute to the development 56 of visceral hypersensitivity and represent potential targets for therapeutic intervention. The 57 distal colon receives dual sensory innervation from afferent fibres running within the lumbar 58 splanchnic nerve (LSN) and the pelvic nerve (PN) (Deiteren et al., 2015) . Both nerves have 59 been implicated in the processing of pain from the colorectum, with the PN being identified as 60 the predominant pathway for the signalling of pain in response to rectal distension in humans, 61 and the LSN being identified as the predominant pathway for the signalling of pain in 62 responses to distension of the sigmoid and descending colon (Hughes et al., 2009; Brierley et 63 al., 2004; Ray and Neill, 1947) . Therefore, the modulation of LSN and PN signalling from 64 respective colonic and rectal regions have important implications in the treatment of chronic 65 visceral pain in GI diseases such as IBS and IBD (Brierley et al., 2004; Siri et al., 2019) . 66
One method by which colorectal sensory nerves can be modulated is through local release of 67 peptides, such as calcitonin gene-related peptide (CGRP), contained within the nerves 68 themselves, or from non-neuronal cells within the GI tract (Lakhan and Kirchgessner, 2010) . 69
We have shown through single-cell RNA sequencing that the peptide galanin is highly 70 expressed in colonic sensory neurones that also express Trpv1, i.e. putative nociceptors, 71 suggesting a potential role in the regulation of colonic nociception (Hockley et al., 2019) . 72
Galanin acts upon 3 receptors, GalR1, GalR2 and GalR3 (Branchek et al., 2000 , and 73 single-cell RNA sequencing demonstrates that GalR1 is the most highly expressed in colonic 74 sensory neurones and that its expression, along with that of GalR2, is largely restricted to 75 Trpv1 positive thoracolumbar DRG arising from the LSN, thus suggesting a paracrine role for 76 galanin in the regulation of sensory signalling from the bowel (Hockley et al., 2019) . When 77 activated by galanin, GalR1 predominantly signals through Gi, suggesting that the effects of 78 galanin on colonic afferent signalling will be inhibitory (Branchek et al., 2000) . Consistent with 79 this supposition, in the upper GI tract of mice and ferrets, galanin produces inhibition of vagal 80 afferent signalling through the activation of GalR1 receptors. Galanin has also been shown to 81 have a stimulatory effect on vagal afferents through the activation of its Gq coupled GalR2 82 receptor, with GalR3 receptors making no clear functional contribution despite its expression 83 in the relevant ganglia (Page et al., 2007 (Page et al., , 2005 . 84
The role of galaninergic signalling in the colorectum is currently unclear and in this study, we 85 set out to determine the effect of galanin upon LSN mechanosensitivity due to the high 86 expression of both galanin and its receptors in the relevant thoracolumbar sensory ganglia. 87
Moreover, because single-cell RNA-sequencing data demonstrate coexpression of GalR1 with 88 receptors for certain inflammatory mediators (e.g. bradykinin and 5-hydroxytryptamine) and 89 ion channels such as Trpv1 that are modulated by inflammatory mediators (Hockley et al., 90 2019), we wanted to determine if galanin could inhibit mechanical hypersensitivity induced by 91 inflammatory mediators and extend this to an in vivo model of acute colitis. 92
We find that galanin is expressed by putative nociceptors originating from the LSN and that it 93 inhibits LSN mechanosensitivity via GalR1. Inflammatory mediator induced mechanical 94 hypersensitivity is also abolished by galanin, but that inhibition of mechanical hypersensitivity 95 is lost in LSN obtained from mice with colitis. 96
Materials and Methods 97
Ethical Approval 98 C57BL/6J mice were used for all experiments. All protocols were performed in accordance 99 with the UK Animals (Scientific Procedures) Act 1986 Amendment Regulations 2012 following 100 ethical review by the University of Cambridge Animal Welfare and Ethical Review Body. 101 102
Ex vivo mouse LSN preparation and recording 103
Adult (8-25 weeks) C57BL/6J male and female mice (Envigo) were humanely killed by cervical 104 dislocation and exsanguination, and the distal colon (from the splenic flexure to rectum) with 105 associated LSN removed. Colonic content was flushed with Krebs buffer and the colon tied to 106 either end of a cannula, and perfused luminally (200 μL min -1 ), and serosally (7 mL min -1 ) with 107 carboxygenated (95% O2, 5% CO2) Krebs buffer, in mM: 124 NaCl, 4.8 KCl, 1.3 NaH2PO4, 2.5 108 CaCl2, 1.2 MgSO4·7H2O, 11.1 glucose, and 25 NaHCO3; supplemented with indomethacin (3 109 μM, to suppress prostanoid synthesis), and nifedipine (10 μM) and atropine (10 μM) to block 110 smooth muscle contraction as previously described (Hockley et al., 2014) . The bath was 111 maintained at 32-34°C. The inferior and superior mesenteric ganglia were identified at the 112 point of the iliac bifurcation and suction electrode recordings of multiunit activity were made 113 from neurovascular bundles isolated central to the inferior mesenteric ganglia. Signals were 114 amplified at a gain of 5K, band pass filtered (100-1300 Hz), digitally filtered for 50 Hz noise 115 (Humbug, Quest Scientific, Canada) and data acquired at 20 kHz (micro1401; Cambridge 116
Electronic Design, UK). Ongoing nerve discharge was quantified from spikes passing a 117 threshold level set at twice the background noise (typically ~100 μV). All signals were 118 displayed on a PC using Spike 2 software. The baseline pressure was set up at 2-3 mmHg 119 and recordings were maintained for approximately 30 minutes before initiating the 120 experimental protocols. 121
122
Mechanosensitivity was evaluated using ramp and phasic distension protocols. For the ramp 123 distension protocol the luminal outflow cannula was blocked and the subsequent increase in 124 pressure was observed until the desired maximum of 80 mmHg was reached (~2.5 minutes), 125 at which point the luminal outflow was re-opened. For the phasic distension protocol a rapid 126 increase in the intraluminal pressure from 0-80 mmHg was achieved by switching the luminal 127 outflow to a water column of sufficient height. 128
For drug treatments, two protocols were used. In one protocol three phasic distensions were 129 performed to obtain a stable response to distension, and then galanin or vehicle (or the 130 GalR1/2 agonists M617 and spexin respectively, Tocris) were serosally superfused (20 mL 131 6 volume) between the third and fourth phasic distension. In the second protocol the effect of 132 galanin (or vehicle) was examined on ramp and phasic distension (an initial ramp distension 133 followed by three phasic distensions) in non-sensitised preparations (continual luminal 134 perfusion with Krebs buffer) or sensitised preparations. Sensitisation was achieved by 135
intraluminal perfusion of an inflammatory soup that has previously been shown to increase 136 resting afferent activity (Su and Gebhart, 1998 : 10 μM histamine, 10 μM prostaglandin E2, 10 137 μM 5HT, 1 μM bradykinin, and 1 mM ATP) for 20 minutes prior to and during subsequent ramp 138 and phasic distensions. 139 140
Analysis of electrophysiological recordings 141
Phasic distension of the colon by 80 mmHg leads to an increase in LSN activity, which consists 142 of an initial peak response that reduces in magnitude to a sustained increase in nerve 143 discharge for the remainder of the distension period. Nerve discharge returning to baseline 144 levels following cessation of the phasic distension. Peak changes and time profiles of LSN 145 activity were determined by subtracting baseline firing (average over 60 seconds before 146 distension) from increases in LSN activity following distension. During phasic distensions, 147 peak firing was defined as the maximal firing rate observed during distensions, occurring within 148 the first 15 seconds, and sustained firing frequency was defined as the activity seen during 149 the subsequent 45 seconds of the phasic distension. Drug effect was determined by 150 comparing an average of the first 3 distensions to the response of the third post-drug 151 distension. By contrast, ramp distension leads to a slow and steady increase in activity until 152 the end of the distension. Pressure profiles of LSN activity were determined by subtracting 153 baseline firing from peak LSN activity measured every 5 mmHg. 154 155
Retrograde labelling of colonic sensory neurones 156
Retrograde labelling of colonic sensory neurones was conducted as previously described 157 (Hockley et al., 2019) . In brief, C57BL/6J mice were anaesthetized with isoflurane (4% 158 induction and 1-2% maintenance) then a midline laparotomy (~1.5 cm incision) performed to 159 reveal the distal colon. Five injections of 0.2 μL Fast Blue (2% in saline, Polysciences GmbH, 160
Germany) were made into the wall of the distal colon using a glass needle at a rate of 0.4 μL 161 min -1 using a microinfusion pump (Harvard Apparatus). After the abdominal cavity was flushed 162 with saline to remove any excess Fast Blue dye, the muscle and skin layers were sutured and 163 secured using 4-6 Michel clips. Postoperative care and analgesia (buprenorphine 0.05-0.1 mg 164 kg -1 ) was provided and a glucose enriched soft diet provided, with regular checks of body 165 7 weight. After a minimum of three days, the animals were killed using sodium pentobarbital 166 (200 mg kg -1 i.p.) and transcardially perfused with phosphate buffered saline (PBS) followed 167 by paraformaldehyde (4% in PBS; pH 7.4). Dorsal root ganglia (DRG; T13 -L1) were removed 168 and further fixed in 4% paraformaldehyde for 30 minutes at 4 °C before cryoprotection in 30% 169 sucrose overnight at 4 °C. The tissue was then embedded in Shandon M-1 Embedding Matrix 170 (Thermo Fisher Scientific), snap frozen in liquid nitrogen, and stored at -80 °C until needed. 171
Cryostat (Leica, CM3000; Nussloch) sections (12 μm) were collated across 10 slides 172 (Superfrost Plus, Thermo Fisher Scientific) for each DRG. 173 174 Immunohistochemistry 175 DRG sections were washed with PBS (twice for 2 minutes) and then blocked using antibody 176 diluent (10% donkey serum, 5% bovine serum albumin and 0.2% Triton X-100 in 0.1 M PBS) 177
for one hour. This was followed by overnight incubation at 4 °C with the appropriate primary 178 antibodies ( Table 1 , we thank Prof. Theodorsson, Linköping University, for the kind gift of the 179 anti-galanin antibody). The sections were then washed three times for five minutes with PBS 180 and then incubated for 2 hours at room temperature with the appropriate fluorophore 181 conjugated secondary antibodies (Table 2) 
. No labelling was observed in control experiments 182
where the primary antibody was excluded or in the presence of galanin as a blocking peptide 183 for the anti-galanin antibody. 184 185 
Imaging and quantification 186
Sections were imaged using an Olympus microscope (BX51) with Qicam camera and the 187 relative intensities of DRG neurones after immunostaining were measured (ImageJ 1.51n 188 analysis software, NIH, USA). The mean background intensity was subtracted to control for 189 variability in illumination between images. Percentages of relative intensities were determined 190 by comparison with least intensely (0%) and the most intensely (100%) labelled cells for each 
Histology: H&E with alcian blue staining 215
Cryostat sections of colon (20 μm) were collected and stored at -20 °C until needed. Slides 216 were washed in tap water for 2 minutes before staining for 5 minutes with haematoxylin (1:2 217 dilution with tap water; Sigma), washing in tap water for 3 minutes followed by 0.3% HCl in 218 ethanol for 30 seconds and then immediately washing in tap water for a further 2 minutes, 219 before incubating in tap water until the tissue developed a deep blue appearance. Slides were 220 then stained with alcian blue (1% W/V in 3% acetic acid; Polysciences Inc) for 10 minutes and 221 washed in tap water for 2 minutes before being immersed in 100% ethanol for 30 seconds. 222
Slides were then stained with eosin (Acros Organics) for 90 seconds, washed in tap water for 223 1 minute and then dehydrated in 100% ethanol for 30 seconds followed by 70% ethanol for 224 Data are presented as mean ± SD, N = number of animals, and n = number of cells. 248
Results 249

Galanin inhibits mechanically evoked LSN firing 250
Single-cell RNA-sequencing of colonic sensory neurones suggests that galanin is expressed To determine the effect of galanin on LSN mechanosensitivity, we measured the effects of 500 270 nM galanin on the response to a ramp distension of the colon (0 -80 mmHg) and observed a 271 robust inhibition of spike frequency across the pressure range used, an effect that was most 272 pronounced at the 80 mmHg ( Fig. 1B and C) . We therefore used a rapid phasic distension of 273 the colon to noxious pressure (80 mmHg) to investigate the dose-dependent effect of galanin 274 upon LSN mechanosensitivity. Galanin inhibited LSN firing in a dose-dependent manner, with 275 the response to galanin being most marked on the third phasic distension after galanin infusion 276
(subsequent values are therefore taken from this third distension, Fig. 1D ). The maximal 277 inhibition of the peak afferent response to phasic colonic distension was observed following 278 the application of 500 nM galanin which produced an approximately 50% reduction in afferent 279 mechanosensitivity (53.3 ± 12.8 spikes s -1 vs 25.2 ± 5.2 spikes s -1 , N = 5, P < 0.0008, one-280 way ANOVA with Tukey's test) and the IC50 calculated from the data was 65.7 nM (Fig. 1E) . 
Galanin inhibits noxious mechanically evoked neuronal excitation via GalR1 305
Having determined that galanin inhibited colonic afferent mechanosensitivity we next 306 investigated the effect of GalR1 and GalR2 agonists on LSN activity. Using the same protocol 307 as for galanin, the selective GalR1 agonist M617 (500 nM) elicited a reduction in LSN 308 mechanosensitivity comparable in magnitude to galanin at 500 nM, such that the peak LSN 309 response to mechanical distension was inhibited from 77.4 ± 10.3 spikes s -1 vs 46.5 ± 8.8 310 spikes s -1 ( Fig. 2A ; P = 0.0015, N = 4, paired t-test) and the sustained response was also 311 inhibited from 37.3 ± 8.8 spikes s -1 vs 22.6 ± 6.9 spikes s -1 ( Fig. 2B ; P = 0.038, N = 4, paired 312 t-test). The effect of 500 nM M617 was similar to that of 500 nM galanin: M671 attenuated 313 peak firing frequency by 41.4 ± 7.5% and 500 nM galanin inhibited peak firing frequency by 314 49.3 ± 16.9% (M617 N = 4, galanin N = 5). By contrast, 1 µM of the endogenous GalR2 agonist 315 spexin, which shows no binding to GalR1 (Kim et al., 2014) , had no effect on LSN colonic 316 afferent mechanosensitivity in response to phasic distension of the colon (Fig. 2C and D) . 
Galanin inhibits mechanical hypersensitivity induced by inflammatory mediators 329
We next investigated the effect of galanin on the sensitisation of the LSN afferent response to 330 colonic distension by intraluminal perfusion with an inflammatory soup (IS: ATP, histamine, 331 PGE2, bradykinin, and serotonin) (Hockley et al., 2014; Su and Gebhart, 1998) . The IS was 332 intraluminally perfused following the third phasic distension (either alone or with 500 nM of 333 galanin, Fig. 3A-D) . As expected, IS significantly increased the peak firing frequency in 334 response to phasic distension (31.2 ± 28.1 %, P < 0.05, N = 6, one-way ANOVA with Tukey's 335 test, Fig. 3E ), whereas co-application of IS and galanin did not produce a significant change 336 in peak afferent firing compared to control (Fig. 3E) . A similar effect was observed with regard 337 to the sustained firing frequency, such that IS application significantly increased sustained 338 firing frequency (40.3 ± 26.7 %, P < 0.05, N = 6, one-way ANOVA with Tukey's test), which 339 was not observed when IS was combined with 500 nM galanin (Fig. 3F) . Lastly, we also 340 observed that the basal LSN activity increased by 81.6 ± 19.3% following IS application (P < 341 0.01, N = 6, one-way ANOVA with Tukey's test), but that combination of IS and galanin did not 342 significantly change the basal firing from the control group, suggesting again that the effects 343 of galanin and IS cancel each other out (Fig. 3G) . 344
345
To further investigate LSN hypersensitivity caused by IS application and how this is affected 346 by galanin, we used a ramp distention (0 to 80 mmHg over ~2.5 minutes). As expected, IS 347 significantly increased activity across a broad range of pressures (Fig. 3H, N = 6) , and again 348 the combination of IS and galanin resulted in a pressure-induced activity relationship that was 349 not significantly different to control (Fig. 3I, N = 6) . These results demonstrate that galanin 
Galanin does not inhibit DSS-induced mechanical hypersensitivity 380
Using the DSS model of colitis, we observed that DSS treated mice showed significant weight 381 loss from day 4 onwards compared to untreated mice (e.g. on day 7, 82.1 ± 1.9% vs 103.9 ± 382 3.6 % of starting weight, N = 10, P <0.0001, unpaired t-test) (Fig. 4A) , and also a significant 383 increase in disease activity index (DAI, Fig. 4B ). Following dissection, colon length was 384 observed to be significantly decreased ( Fig. 4C and D) and the colon wet weight to length ratio 385 was also significantly increased in DSS mice compared to the control group (Fig. 4E) . We 386 observed both significant macroscopic and histological damage (Fig. 4F-H inflammation. Using a ramp distention, we observed that the LSN isolated from DSS treated 429 mice produced a greater response at non-nociceptive pressure (20 mmHg, 6.9 ± 5 spikes s -1 430 vs 19.8 ± 4.7 spikes s -1 , P = 0.0184, N = 6, t-test), but not at nociceptive pressure compared 431 to the LSN from healthy mice (34.7 ± 8.1 spikes s -1 vs 39.7 ± 3.2 spikes s -1, P = 0.137, N = 6, 432
Student's T-test; 80 mmHg, Fig. 5A ). In addition, the basal firing of LSN from DSS treated mice 433 was significantly greater than that of healthy mice (3.9 ± 1.4 spikes s -1 vs 28.4 ± 13.4 spikes 434 s -1 , P = 0.012 , N = 6, Student's T-test). Together with the ramp distension response data, 435 these results suggest that DSS induced a state of visceral hypersensitivity at the level of the 436 primary afferent. Whereas galanin was observed to significantly inhibit the peak and sustained 437 LSN responses induced by a phasic distension to 80 mmHg of the colon in healthy mice ( Fig.  438 1), no such inhibitory effect was observed when measuring LSN activity in nerves isolated 439 from DSS mice: peak firing frequency (65.7 ± 16.6 spikes s -1 vs 66.6 ± 22.3 spikes s -1 , P = 440 0.81, N = 6, paired t-test; Fig. 5B ) and sustained firing frequency (34.1 ± 9.9 spikes s -1 vs 41.9 441 ± 14 spikes s -1 , P = 0.54, N = 6, paired t-test; Fig. 5C ) induced by a phasic distension to 80 442 mmHg were affected by administration of galanin. These results indicate that the inhibitory 443 action of galanin is lost in tissue isolated from mice with acute colitis. behaviour in animals (Gebhart, 2004; Ness et al., 1990) . Consequently, distension is a useful 478 tool when defining noxious responses in afferent preparations and examining hyperexcitability 479 to colonic inflammation. We find from multi-unit recordings of LSN activity that galanin inhibits 480 mechanically-evoked responses to distension of the distal colon to noxious pressures and the 481 sensitisation of these responses following addition of inflammatory stimuli. This suggests that 482 galanin receptors, specifically in the case of the LSN GalR1, function as integral regulators of 483 neuronal excitability. Multiple populations of sensory afferents innervate the distal colon with 484 differing sensitivities to mechanical stimuli (e.g. stretch, stroke and von Frey hair probing of 485 their receptive fields) (Brierley et al., 2004 ) and whilst we did not seek to characterise these 486 groups more specifically, we did observe inhibitory effects of galanin across the full range of 487 distension pressures from physiological through to noxious (i.e. 0 -80 mmHg, Fig. 1C ). When 488 examining the expression of galanin, both colonic sensory neurone RNA-sequencing and 489 immunohistochemistry ( Fig. 1A) demonstrate that galanin is expressed in putative nociceptors 490 (Hockley et al., 2019) . With regard to GalR1, colonic sensory neurone RNA-sequencing 491 indicates that it is predominantly expressed in neurones expressing nociceptor markers, such 492
as Trpv1 and Gfrα3, as well as in a population of neurones expressing the mechanosensitive 493 ion channel Piezo2, an expression pattern that likely explains the inhibitory impact of galanin 494 on LSN activity across a wide range of pressures (Fig. 1C) . The GalR1 receptor is coupled to 495 G protein-coupled inwardly rectifying potassium channels (GIRKs) giving rise to 496 hyperpolarization (Walker et al., 1997; Smith et al., 1998) , an effect that would account for the 497 inhibitory activity of galanin observed in this study. This conclusion is further supported by data 498 demonstrating that inhibition of LSN activity was also produced by the GalR1 agonist M617, 499 but not the GalR2 agonist spexin (Fig. 2) . 500
As observed in previous studies (Su and Gebhart, 1998) , we found that intraluminal application 501 of IS produced robust LSN hyperexcitability to mechanical stimuli (Fig. 3) . Part of this 502 hyperexcitability likely results from recruitment of 'silent' or mechanically insensitive afferents 503 in both the LSN and PN (Feng and Gebhart, 2011) , potentially through disinhibition of Piezo2 504 (Prato et al., 2017) . The ability of galanin to reverse the mechanically hypersensitivity induced 505 by the IS correlates with the fact that a variety of inflammatory mediator receptors are present 506 in colonic sensory neurones that also express GalR1 (Hockley et al., 2019) . However, by 507 contrast, galanin was not able to reduce the mechanical hypersensitivity present in LSN 508 isolated from mice treated with DSS to induce a state of colitis. 509 510 Why is it that galanin counteracts the acute effects of inflammatory mediators on LSN activity, 511
but has no such effect on LSN activity in a mouse model of colitis? It has been observed that 512 galanin receptor expression is altered in certain models of inflammation and hence differential 513 receptor expression could lead to galanin no longer exerting an inhibitors effect. For example, 514 following hind-paw injection of carrageenan in rats, GalR1 mRNA expression in DRG neurones 515 (L4 and L5) decreases (Xu et al., 1996) and a similar decrease in GalR1 expression could 516 occur in the DSS model and hence galanin is no longer able to inhibit mechanically-evoked 517 LSN activity; alternatively, there could be an increase in the expression of excitatory GalR2. 518
The absence of reliable tools to investigate GalR protein levels and the validity of current 519 antibodies being uncertain (Lu and Bartfai, 2009) makes quantifying the protein level of GalRs 520 in colonic afferents a significant challenge. However, there are also alternative explanations 521 for the lack of measurable galanin activity. For example, multiple inflammatory mediators are 522 released from inflamed colon tissue (Spiller and Major, 2016) , which would act upon a broad 523 range of afferents to induce a variety of transcriptional changes and post-translational 524 modifications, i.e. both GalR1+ve and GalR1-ve afferents, and thus the mechanical 525 hypersensitivity observed in LSN isolated from DSS treated mice is likely at least partially 526 mediated via GalR1-ve afferents. Therefore, any effect of galanin on the whole-nerve 527 response may simply be overcome by the overall level of sensitisation. A further explanation 528 would be that the coupling of GalR1 is altered in inflammation due to altered expression of G 529
